These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 28137963)

  • 1. The Role of Efferocytosis in Atherosclerosis.
    Kojima Y; Weissman IL; Leeper NJ
    Circulation; 2017 Jan; 135(5):476-489. PubMed ID: 28137963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The walking dead: macrophage inflammation and death in atherosclerosis.
    Kavurma MM; Rayner KJ; Karunakaran D
    Curr Opin Lipidol; 2017 Apr; 28(2):91-98. PubMed ID: 28134664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis.
    Wang Z; Su J; Gong F; Xue L; Su Z
    J Cardiovasc Pharmacol; 2022 Sep; 80(3):407-416. PubMed ID: 35853202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
    Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
    Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic cell death and efferocytosis in atherosclerosis.
    Van Vré EA; Ait-Oufella H; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):887-93. PubMed ID: 22328779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
    Thorp E; Tabas I
    J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of efferocytosis in atherosclerosis.
    Shu LX; Cao LL; Guo X; Wang ZB; Wang SZ
    J Mol Med (Berl); 2024 Jul; 102(7):831-840. PubMed ID: 38727748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis.
    Wang L; Li H; Tang Y; Yao P
    Front Endocrinol (Lausanne); 2020; 11():585285. PubMed ID: 33597922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis.
    Tajbakhsh A; Kovanen PT; Rezaee M; Banach M; Moallem SA; Sahebkar A
    Int J Biochem Cell Biol; 2020 Mar; 120():105684. PubMed ID: 31911118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Apoptosis and Necrotic Core Development in Atherosclerosis: A Rapidly Advancing Field with Clinical Relevance to Imaging and Therapy.
    Gonzalez L; Trigatti BL
    Can J Cardiol; 2017 Mar; 33(3):303-312. PubMed ID: 28232016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efferocytosis of vascular cells in cardiovascular disease.
    Cabrera JTO; Makino A
    Pharmacol Ther; 2022 Jan; 229():107919. PubMed ID: 34171333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet.
    Li S; Sun Y; Liang CP; Thorp EB; Han S; Jehle AW; Saraswathi V; Pridgen B; Kanter JE; Li R; Welch CL; Hasty AH; Bornfeldt KE; Breslow JL; Tabas I; Tall AR
    Circ Res; 2009 Nov; 105(11):1072-82. PubMed ID: 19834009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.
    Linton MF; Babaev VR; Huang J; Linton EF; Tao H; Yancey PG
    Circ J; 2016 Oct; 80(11):2259-2268. PubMed ID: 27725526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efferocytosis: molecular mechanisms and pathophysiological perspectives.
    Gheibi Hayat SM; Bianconi V; Pirro M; Sahebkar A
    Immunol Cell Biol; 2019 Feb; 97(2):124-133. PubMed ID: 30230022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constructing Mal-Efferocytic Macrophage Model and Its Atherosclerotic Spheroids and Rat Model for Therapeutic Evaluation.
    Zou D; Yang P; Liu J; Dai F; Xiao Y; Zhao A; Huang N
    Adv Biol (Weinh); 2023 Jun; 7(6):e2200277. PubMed ID: 36721069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and consequences of macrophage apoptosis in atherosclerosis.
    Seimon T; Tabas I
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S382-7. PubMed ID: 18953058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Efferocytosis in Atherosclerotic Lesions In Situ.
    Yurdagul A
    Methods Mol Biol; 2022; 2419():561-567. PubMed ID: 35237988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.
    Jarr KU; Kojima Y; Weissman IL; Leeper NJ
    Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):e145-e154. PubMed ID: 35387480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.
    Heo KS; Cushman HJ; Akaike M; Woo CH; Wang X; Qiu X; Fujiwara K; Abe J
    Circulation; 2014 Jul; 130(2):180-91. PubMed ID: 25001623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
    Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.